Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

ANXA6 Contributes to Radioresistance by Promoting Autophagy via Inhibiting the PI3K/AKT/mTOR Signaling Pathway in Nasopharyngeal Carcinoma

16 Apr 2020

Abstract excerpt

Radiotherapy is a conventional and effective treatment method for nasopharyngeal carcinoma (NPC) although the residual and recurrent tumors due to radioresistance are the main reasons for the failure of radiotherapy. However, the mechanism and predictive marker of NPC radioresistance are still obscure. In this study, we identified Annexin A6 (ANXA6) as a candidate of radioresistance marker by using Tandem Mass...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Autophagy in Disease and Therapy
Share to Cancer-related gene regulation
Share to S100 Proteins and Annexins

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 32373608
DOI: 10.3389/fcell.2020.00232

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

ANXA6 Contributes to Radioresistance by Promoting Autophagy via Inhibiting the PI3K/AKT/mTOR Signaling Pathway in Nasopharyngeal CarcinomaPMID 32373608Read ↗

lncRNA CASC19 Contributes to Radioresistance of Nasopharyngeal Carcinoma by Promoting Autophagy via AMPK-mTOR PathwaySemantic proximity Read ↗

Autophagy-related lncRNAs in tumor progression and drug resistance: A double-edged swordSemantic proximity Read ↗

The Multifaceted Role of Autophagy in Nasopharyngeal Carcinoma: Translational Perspectives on Pathogenesis, Biomarkers, Treatment Resistance, and Emerging TherapiesSemantic proximity Read ↗

Targeting annexin A2 reduces tumorigenesis and therapeutic resistance of nasopharyngeal carcinoma.Semantic proximity Read ↗

CRISPR/Cas9 genome-wide screening identifies LUC7L2 that promotes radioresistance via autophagy in nasopharyngeal carcinoma cellsSemantic proximity Read ↗

iTRAQ-based quantitative proteomic analysis of differentially expressed proteins in chemoresistant nasopharyngeal carcinomaSemantic proximity Read ↗

IGF2BP1-HAX-1 positive feedback loop-mediated HAX-1 overexpression blocks autophagic flux and promotes chemoresistance in nasopharyngeal carcinomaSemantic proximity Read ↗

The role of radiotherapy-related autophagy genes in the prognosis and immune infiltration in lung adenocarcinomaSemantic proximity Read ↗

Small biomarkers with massive impacts: PI3K/AKT/mTOR signalling and microRNA crosstalk regulate nasopharyngeal carcinomaSemantic proximity Read ↗

Annexin A11(ANXA 11) facilitates oral squamous cell carcinoma progression via activating the PI3K/AKT signaling pathwaySemantic proximity Read ↗

Inhibition of autophagy enhances the radiosensitivity of nasopharyngeal carcinoma by reducing Rad51 expressionSemantic proximity Read ↗

Multiple Mechanisms Involving in Radioresistance of Nasopharyngeal CarcinomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.